Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain
- 1 November 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pain
- Vol. 152 (11), 2564-2574
- https://doi.org/10.1016/j.pain.2011.07.020
Abstract
Summary As cancer cell colonies proliferate, undergo necrosis, and metastasize in bone, sensory and sympathetic nerve fibers also undergo a concomitant sprouting, degeneration, and resprouting. ABSTRACT Early, preemptive blockade of nerve growth factor (NGF)/tropomyosin receptor kinase A (TrkA) attenuates tumor-induced nerve sprouting and bone cancer pain. A critical unanswered question is whether late blockade of NGF/TrkA can attenuate cancer pain once NGF-induced nerve sprouting and neuroma formation has occurred. By means of a mouse model of prostate cancer-induced bone pain, anti-NGF was either administered preemptively at day 14 after tumor injection when nerve sprouting had yet to occur, or late at day 35, when extensive nerve sprouting had occurred. Animals were humanely killed at day 70 when, in vehicle-treated animals, significant nerve sprouting and neuroma formation was present in the tumor-bearing bone. Although preemptive and sustained administration (days 14–70) of anti-NGF more rapidly attenuated bone cancer nociceptive behaviors than late and sustained administration (days 35–70), by day 70 after tumor injection, both preemptive and late administration of anti-NGF significantly reduced nociceptive behaviors, sensory and sympathetic nerve sprouting, and neuroma formation. In this model, as in most cancers, the individual cancer cell colonies have a limited half-life because they are constantly proliferating, metastasizing, and undergoing necrosis as the parent cancer cell colony outgrows its blood supply. Similarly, the sensory and sympathetic nerve fibers that innervate the tumor undergo sprouting at the viable/leading edge of the parent tumor, degenerate as the parent cancer cell colony becomes necrotic, and resprout in the viable, newly formed daughter cell colonies. These results suggest that preemptive or late-stage blockade of NGF/TrkA can attenuate nerve sprouting and cancer pain.Keywords
This publication has 67 references indexed in Scilit:
- Breast Cancer-Induced Bone Remodeling, Skeletal Pain, and Sprouting of Sensory Nerve FibersThe Journal of Pain, 2011
- The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase ANeuroscience, 2011
- Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer painNeuroscience, 2010
- Pathological Sprouting of Adult Nociceptors in Chronic Prostate Cancer-Induced Bone PainJournal of Neuroscience, 2010
- Mechanism of Cancer PainMolecular Interventions, 2010
- Administration of a Tropomyosin Receptor Kinase Inhibitor Attenuates Sarcoma-Induced Nerve Sprouting, Neuroma Formation and Bone Cancer PainMolecular Pain, 2010
- Bone Cancer Induces a Unique Central Sensitization through Synaptic Changes in a Wide Area of the Spinal CordMolecular Pain, 2010
- Tumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer painBrain Research, 2007
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983